{"transactions":[{"id":2108702,"issuer":{"id":5512,"kind":"organization","name":"Strata Critical Medical, Inc.","symbol":"SRTA"},"owners":[{"id":122231,"kind":"person","name":"Keene Brandon A.","position":1,"cik":"0001859733","reported_name":"Keene Brandon A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Class A common stock, $0.0001 par value per share","published_at":"2022-11-21T21:37:48.000Z","date":"2022-11-18","kind":"sale","acquired":false,"shares":20000,"price":4.7536,"value":95072.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.73 to $4.815, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":318589,"source":{"system":"sec-edgar","filing":"0001779128-22-000124","document":"wf-form4_166906663653152.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1779128/000177912822000124/wf-form4_166906663653152.xml","form_type":"4"}},{"id":2108701,"issuer":{"id":5512,"kind":"organization","name":"Strata Critical Medical, Inc.","symbol":"SRTA"},"owners":[{"id":122231,"kind":"person","name":"Keene Brandon A.","position":1,"cik":"0001859733","reported_name":"Keene Brandon A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Class A common stock, $0.0001 par value per share","published_at":"2022-11-21T21:37:48.000Z","date":"2022-11-18","kind":"sale","acquired":false,"shares":9103,"price":4.881,"value":44431.743,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.85 to $4.915, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":338589,"source":{"system":"sec-edgar","filing":"0001779128-22-000124","document":"wf-form4_166906663653152.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1779128/000177912822000124/wf-form4_166906663653152.xml","form_type":"4"}},{"id":2139267,"issuer":{"id":5512,"kind":"organization","name":"Strata Critical Medical, Inc.","symbol":"SRTA"},"owners":[{"id":122231,"kind":"person","name":"Keene Brandon A.","position":1,"cik":"0001859733","reported_name":"Keene Brandon A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Class A common stock, $0.0001 par value per share","published_at":"2022-10-11T14:16:11.000Z","date":"2022-10-06","kind":"sale","acquired":false,"shares":1283,"price":3.9706,"value":5094.2798,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.97 to $3.9986, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":347692,"source":{"system":"sec-edgar","filing":"0001779128-22-000100","document":"wf-form4_166549775309037.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1779128/000177912822000100/wf-form4_166549775309037.xml","form_type":"4"}},{"id":2159397,"issuer":{"id":5512,"kind":"organization","name":"Strata Critical Medical, Inc.","symbol":"SRTA"},"owners":[{"id":122231,"kind":"person","name":"Keene Brandon A.","position":1,"cik":"0001859733","reported_name":"Keene Brandon A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Class A common stock, $0.0001 par value per share","published_at":"2022-09-14T21:17:06.000Z","date":"2022-09-14","kind":"sale","acquired":false,"shares":35000,"price":4.724,"value":165340.0,"ownership":{"direct":true},"balance_after":348975,"source":{"system":"sec-edgar","filing":"0001779128-22-000093","document":"wf-form4_166319021258597.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1779128/000177912822000093/wf-form4_166319021258597.xml","form_type":"4"}},{"id":2159396,"issuer":{"id":5512,"kind":"organization","name":"Strata Critical Medical, Inc.","symbol":"SRTA"},"owners":[{"id":122231,"kind":"person","name":"Keene Brandon A.","position":1,"cik":"0001859733","reported_name":"Keene Brandon A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Class A common stock, $0.0001 par value per share","published_at":"2022-09-14T21:17:06.000Z","date":"2022-09-13","kind":"sale","acquired":false,"shares":5000,"price":4.82,"value":24100.0,"ownership":{"direct":true},"balance_after":383975,"source":{"system":"sec-edgar","filing":"0001779128-22-000093","document":"wf-form4_166319021258597.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1779128/000177912822000093/wf-form4_166319021258597.xml","form_type":"4"}},{"id":2159395,"issuer":{"id":5512,"kind":"organization","name":"Strata Critical Medical, Inc.","symbol":"SRTA"},"owners":[{"id":122231,"kind":"person","name":"Keene Brandon A.","position":1,"cik":"0001859733","reported_name":"Keene Brandon A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Class A common stock, $0.0001 par value per share","published_at":"2022-09-14T21:17:06.000Z","date":"2022-09-12","kind":"sale","acquired":false,"shares":10000,"price":5,"value":50000.0,"ownership":{"direct":true},"balance_after":388975,"source":{"system":"sec-edgar","filing":"0001779128-22-000093","document":"wf-form4_166319021258597.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1779128/000177912822000093/wf-form4_166319021258597.xml","form_type":"4"}},{"id":2192008,"issuer":{"id":5512,"kind":"organization","name":"Strata Critical Medical, Inc.","symbol":"SRTA"},"owners":[{"id":122231,"kind":"person","name":"Keene Brandon A.","position":1,"cik":"0001859733","reported_name":"Keene Brandon A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Class A common stock, $0.0001 par value per share","published_at":"2022-08-08T14:27:55.000Z","date":"2022-07-15","kind":"tax_withholding","acquired":false,"shares":904,"price":4.41,"value":3986.64,"ownership":{"direct":true},"balance_after":398975,"source":{"system":"sec-edgar","filing":"0001779128-22-000076","document":"wf-form4_165996886078436.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1779128/000177912822000076/wf-form4_165996886078436.xml","form_type":"4"}},{"id":2218757,"issuer":{"id":5512,"kind":"organization","name":"Strata Critical Medical, Inc.","symbol":"SRTA"},"owners":[{"id":122231,"kind":"person","name":"Keene Brandon A.","position":1,"cik":"0001859733","reported_name":"Keene Brandon A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-06-30T14:58:15.000Z","date":"2022-06-28","kind":"exercise","acquired":false,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":36331,"derivative":{"exercise_price":0.18,"exercise_date":"2021-05-07","expiration_date":"2027-06-27","underlying":"Class A common stock, $0.0001 par value per share","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001779128-22-000065","document":"wf-form4_165660108156332.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1779128/000177912822000065/wf-form4_165660108156332.xml","form_type":"4"}},{"id":2218756,"issuer":{"id":5512,"kind":"organization","name":"Strata Critical Medical, Inc.","symbol":"SRTA"},"owners":[{"id":122231,"kind":"person","name":"Keene Brandon A.","position":1,"cik":"0001859733","reported_name":"Keene Brandon A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Class A common stock, $0.0001 par value per share","published_at":"2022-06-30T14:58:15.000Z","date":"2022-06-28","kind":"exercise","acquired":true,"shares":150000,"price":0.18,"value":27000.0,"ownership":{"direct":true},"balance_after":399879,"source":{"system":"sec-edgar","filing":"0001779128-22-000065","document":"wf-form4_165660108156332.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1779128/000177912822000065/wf-form4_165660108156332.xml","form_type":"4"}},{"id":2236166,"issuer":{"id":5512,"kind":"organization","name":"Strata Critical Medical, Inc.","symbol":"SRTA"},"owners":[{"id":122231,"kind":"person","name":"Keene Brandon A.","position":1,"cik":"0001859733","reported_name":"Keene Brandon A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-06-10T17:30:54.000Z","date":"2022-06-09","kind":"exercise","acquired":false,"shares":72800,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":374644,"derivative":{"exercise_price":0.18,"exercise_date":"2021-05-07","expiration_date":"2028-11-16","underlying":"Class A common stock, par value $0.0001 per share","underlying_shares":72800},"source":{"system":"sec-edgar","filing":"0001779128-22-000061","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1779128/000177912822000061/primary_doc.xml","form_type":"4"}},{"id":2236165,"issuer":{"id":5512,"kind":"organization","name":"Strata Critical Medical, Inc.","symbol":"SRTA"},"owners":[{"id":122231,"kind":"person","name":"Keene Brandon A.","position":1,"cik":"0001859733","reported_name":"Keene Brandon A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Class A common stock, $0.0001 par value per share","published_at":"2022-06-10T17:30:54.000Z","date":"2022-06-09","kind":"exercise","acquired":true,"shares":72800,"price":0.18,"value":13104.0,"ownership":{"direct":true},"balance_after":249879,"source":{"system":"sec-edgar","filing":"0001779128-22-000061","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1779128/000177912822000061/primary_doc.xml","form_type":"4"}},{"id":2258438,"issuer":{"id":5512,"kind":"organization","name":"Strata Critical Medical, Inc.","symbol":"SRTA"},"owners":[{"id":122231,"kind":"person","name":"Keene Brandon A.","position":1,"cik":"0001859733","reported_name":"Keene Brandon A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-05-24T15:40:01.000Z","date":"2022-05-23","kind":"exercise","acquired":false,"shares":62160,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":447444,"derivative":{"exercise_price":0.18,"exercise_date":"2021-05-07","expiration_date":"2030-07-28","underlying":"Class A Common Stock","underlying_shares":62160},"source":{"system":"sec-edgar","filing":"0001779128-22-000057","document":"wf-form4_165340678466948.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1779128/000177912822000057/wf-form4_165340678466948.xml","form_type":"4"}},{"id":2258437,"issuer":{"id":5512,"kind":"organization","name":"Strata Critical Medical, Inc.","symbol":"SRTA"},"owners":[{"id":122231,"kind":"person","name":"Keene Brandon A.","position":1,"cik":"0001859733","reported_name":"Keene Brandon A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Class A common stock, par value $0.0001 per share","published_at":"2022-05-24T15:40:01.000Z","date":"2022-05-23","kind":"exercise","acquired":true,"shares":62160,"price":0.18,"value":11188.8,"ownership":{"direct":true},"balance_after":177079,"source":{"system":"sec-edgar","filing":"0001779128-22-000057","document":"wf-form4_165340678466948.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1779128/000177912822000057/wf-form4_165340678466948.xml","form_type":"4"}},{"id":2302636,"issuer":{"id":5512,"kind":"organization","name":"Strata Critical Medical, Inc.","symbol":"SRTA"},"owners":[{"id":122231,"kind":"person","name":"Keene Brandon A.","position":1,"cik":"0001859733","reported_name":"Keene Brandon A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Class A common stock, $0.0001 par value per share","published_at":"2022-04-06T14:38:59.000Z","date":"2022-04-05","kind":"tax_withholding","acquired":false,"shares":1379,"price":8.6,"value":11859.4,"ownership":{"direct":true},"balance_after":114919,"source":{"system":"sec-edgar","filing":"0001779128-22-000030","document":"wf-form4_164925592612811.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1779128/000177912822000030/wf-form4_164925592612811.xml","form_type":"4"}},{"id":2464022,"issuer":{"id":5512,"kind":"organization","name":"Strata Critical Medical, Inc.","symbol":"SRTA"},"owners":[{"id":122231,"kind":"person","name":"Keene Brandon A.","position":1,"cik":"0001859733","reported_name":"Keene Brandon A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Class A common stock, $0.0001 par value per share","published_at":"2021-12-20T16:33:55.000Z","date":"2021-12-16","kind":"grant","acquired":true,"shares":36390,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of Restricted Stock Units (\"RSUs\"), which will be settled in shares of the Issuer's common stock upon vesting. 6.25% (rounded down to the nearest whole number) will vest every three calendar months from January 1,2022 (with the first tranche to vest on April 1, 2022), with any remaining unvested Restricted Stock Units to vest on January 1, 2026, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":116298,"source":{"system":"sec-edgar","filing":"0001779128-21-000019","document":"wf-form4_164001802290697.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1779128/000177912821000019/wf-form4_164001802290697.xml","form_type":"4"}},{"id":2470005,"issuer":{"id":5512,"kind":"organization","name":"Strata Critical Medical, Inc.","symbol":"SRTA"},"owners":[{"id":122231,"kind":"person","name":"Keene Brandon A.","position":1,"cik":"0001859733","reported_name":"Keene Brandon A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Class A common stock, $0.0001 par value per share","published_at":"2021-12-16T23:27:46.000Z","date":"2021-12-14","kind":"tax_withholding","acquired":false,"shares":6266,"price":8.38,"value":52509.08,"ownership":{"direct":true},"balance_after":79908,"source":{"system":"sec-edgar","filing":"0001779128-21-000012","document":"wf-form4_163969724717443.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1779128/000177912821000012/wf-form4_163969724717443.xml","form_type":"4"}},{"id":2600377,"issuer":{"id":5512,"kind":"organization","name":"Strata Critical Medical, Inc.","symbol":"SRTA"},"owners":[{"id":122231,"kind":"person","name":"Keene Brandon A.","position":1,"cik":"0001859733","reported_name":"Keene Brandon A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Class A common stock, $0.0001 par value per share","published_at":"2021-08-17T22:03:10.000Z","date":"2021-08-13","kind":"grant","acquired":true,"shares":75254,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of Restricted Stock Units (\"RSUs\"), which will be settled in shares of the Issuer's common stock upon vesting. 66.67% of the RSUs will vest on July 1, 2023, and the remaining RSUs will vest on July 1, 2024, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":86174,"source":{"system":"sec-edgar","filing":"0001062993-21-007693","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1779128/000106299321007693/form4.xml","form_type":"4"}}]}